A Syndrome Resembling Adrenal Cortical Insufficiency Associated with Long Term Busulfan (Myleran) Therapy
Open Access
- 1 November 1961
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 18 (5) , 497-510
- https://doi.org/10.1182/blood.v18.5.497.497
Abstract
Four patients who developed a clinical syndrome characterized by hyperpigmentation of the skin, weakness, fatigue, weight loss, anorexia and nausea while on long-term treatment with busulfan were described. The etiology of the disorder, although clearly related to the busulfan therapy, is obscure, but may be related to "dethiolation".Keywords
This publication has 19 references indexed in Scilit:
- Effects of Dietary Supplements in Preventing or Augmenting the Production of Cataracts in Rats by 1,4-Dimethane-SulfonoxybutaneJournal of Nutrition, 1956
- Effect of myleran treatment on the P32 uptake of leukocytic deoxyribonucleic acid in chronic granulocytic leukemiaCancer, 1956
- Treatment of Chronic Granulocytic Leukemia with 1,4-Dimethanesulfonyloxybutane (Myleran)New England Journal of Medicine, 1956
- Myleran (GT 41) in the Treatment of Leukaemia.1Acta Medica Scandinavica, 1955
- CHEMOTHERAPY OF LEUKEMIA, HODGKIN'S DISEASE AND RELATED DISORDERSAnnals of Internal Medicine, 1954
- The effect of 1,4-dimethanesulfonyloxybutane (GT-41 or myleran) upon leukemiaCancer, 1954
- Der Einfluss von Myleran auf die Keimdrüsen von RattenCellular and Molecular Life Sciences, 1953
- MAMMALIAN TYROSINASE: THE RELATIONSHIP OF COPPER TO ENZYMATIC ACTIVITYJournal of Biological Chemistry, 1950
- BIOCHEMISTRY OF MELANIN FORMATIONPhysiological Reviews, 1950
- Inhibitory Action of Human Epidermis on Melanin FormationExperimental Biology and Medicine, 1946